Chris Fashek

Operating Partner at Shore Capital Partners LLC

Chris Fashek

Chris Fashek

Operating Partner at Shore Capital Partners LLC

Overview
Career Highlights

Kinetic Concepts, Inc.
Systagenix Wound Management Ltd.
Atteris Healthcare LLC

RelSci Relationships

802

Number of Boards

9

Birthday

1951

Age

69

Contact Data
Trying to get in touch with Chris Fashek? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Chris Fashek likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer & Director at NanoVibronix, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Hip Innovation Technology LLC

Relationship likelihood: Strong

Founder & Managing Partner at The Catalyst Group, Inc.

Relationship likelihood: Strong

President at NanoVibronix, Inc.

Relationship likelihood: Strong

Vice Chairman at Spiracur, Inc.

Relationship likelihood: Strong

Founder at Spiracur, Inc.

Relationship likelihood: Strong

Senior Director-Human Resources & Communications at Spiracur, Inc.

Relationship likelihood: Strong

Chief Executive & Financial Officer at WiderCircle, Inc.

Relationship likelihood: Strong

Relationship likelihood: Strong

Chief Executive & Financial Officer at Spiracur, Inc.

Relationship likelihood: Strong

Paths to Chris Fashek
Potential Connections via
Relationship Science
You
Chris Fashek
Operating Partner at Shore Capital Partners LLC
Career History
Chief Executive Officer
2016 - Current
Vice Chairman
Current

PUBLIC EDUCATION ABOUT CRANIOFACIAL DEFORMITIES AND MEDICAL CARE FOR CHILDREN WITH CRANIOFACIAL DEFORMITIES.

Operating Partner
Current

Shore Capital Partners focuses on investments in lower middle-market companies in the healthcare sector. For platform investments, the firm targets companies focused on microcap healthcare and food & beverage investments with $5 million to $50 million and EBITDA of $1 million to $5 million. For add-on investments, companies should have at least $1 million in revenues. There is no minimum EBITDA requirement. Shore Capital Partners participates in: family succession transactions, MBOs, LBOs, recapitalizations, industry consolidations, growth investments and corporate divestitures.

Boards & Committees
Vice Chairman, Board of Directors
2016 - Current
Member, Board of Directors
2016 - Current
Member, Board of Directors
Current
Member, Board of Trustees
Prior - 2014
Political Donations
$500
2006
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Chris Fashek. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Chris Fashek's profile does not indicate a business or promotional relationship of any kind between RelSci and Chris Fashek.